Bionomics Reports Topline Results in PREVAIL Phase 2 Study
BNC210 for Treatment of Social Anxiety Disorder (SAD) Did Not Meet Primary EndpointSubjects with Confirmed SAD who Received BNC210 Exhibited Trends Toward...
Source: globenewswire.com
Stay updated with breaking news from Favourable Safety. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BNC210 for Treatment of Social Anxiety Disorder (SAD) Did Not Meet Primary EndpointSubjects with Confirmed SAD who Received BNC210 Exhibited Trends Toward...